Report – How the European Union (EU) ensured safety of medicines during COVID-19

15 giugno 2023 – Preparedness for intensified monitoring, methodologies based on established pharmacovigilance tools as well as on innovative approaches and the flexibility and commitment of all the stakeholders involved were key factors to allow the European medicines regulatory network to effectively respond to the pandemic. These activities are detailed in a PDF icon report published today.

For more information, see here.